CohBar (OTCQX: CWBR) is a biotech company engaged in the research and development of mitochondria-based therapeutics (“MBTs”) to treat various diseases associated with aging and metabolic dysfunction. MBTs originate from a discovery made by CohBar’s founders of a novel group of peptides within the mitochondrial genome which regulate metabolism and cell death, and whose biological activity declines with age. CohBar’s efforts primarily focus on the development of these mitochondrial-derived peptides (“MDPs”) into clinically applicable MBTs that offer the potential to address a broad range of age-related diseases with underlying metabolic dysfunction, including obesity, nonalcoholic steatohepatitis (“NASH”), Type 2 diabetes, cancer, and cardiovascular and neurodegenerative diseases. The company and its founders have discovered more than 100 MDPs to date. For additional company information, please visit www.cohbar.com.
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, please visit https://www.NetworkNewsWire.com